Abstract:Disturbed sleep is a common subjective complaint among individuals with anxiety disorders. Sleep deprivation increases general and specific anxiety symptoms among healthy individuals. The amygdala is critical for regulating anxiety and also involved in mediating the effects of emotions on sleep. Neuropeptide S (NPS) and NPS receptors (NPSR) are reported as a novel endogenous arousal and anxiolytic system, but it is unclear yet whether this system is involved in anxiety-like behavior and sleep caused by sleep deprivation, and how it plays anxiolytic effect underlying the comorbid condition. In the present study, we demonstrate that paradoxical sleep deprivation (PSD) induced by modified multiple platform method (MMPM) for 24 h caused anxiety-like behavior, a prolonged sleep latency and subsequent paradoxical sleep (PS) rebound accompanied by an increase in electroencephalogram (EEG) theta (4.5-8.5 Hz) activities across light and dark phase in rats. The increase of PS after PSD was due to an increase of episode number during light phase and both episode number and duration during dark phase. Central action of NPS (1 nmol) attenuated PSD-induced anxiety-like behavior, and altered PSD-induced sleep-wake disturbances through increasing wakefulness, and suppressing PS and EEG theta activities. The reduction in PS time following NPS administration during light phase was because of a decreased episode number. Furthermore, sleep amount in 24 h in PSD rats given NPS was lesser than that given saline. PSD significantly enhanced NPSR mRNA expression level in the amygdala. NPS remarkably increased the number of Fos-ir neurons in the basolateral amygdala (BLA), the central amygdala (CeA) and medial amygdala (MeA). The majority of Fos-ir neurons induced by NPS also expressed NPSR. These results suggest that NPSR upregulation in the amygdala is presumably related to the PSD-induced anxiety-like behavior and sleep disturbances, and that NPS counteracts PSD-induced anxiety-like behavior and sleep disturbances possibly through activating the neurons bearing NPSR in the amygdala. In addition, the little sleep increase in PSD rats treated with NPS suggests that NPS can function as an anxiolytic without causing a subsequent sleep rebound.

Neuropeptide S Attenuates the Alarm Pheromone-Evoked Defensive and Risk Assessment Behaviors Through Activation of Cognate Receptor-Expressing Neurons in the Posterior Medial Amygdala

Neuropeptide S Facilitates Mice Olfactory Function Through Activation Of Cognate Receptor-Expressing Neurons In The Olfactory Cortex

The Ventromedial Hypothalamic Nucleus Plays an Important Role in Anxiolytic-Like Effect of Neuropeptide S

Neuropeptide S Displays As a Key Neuromodulator in Olfactory Spatial Memory.

Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala

Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-D-aspartate receptor antagonist in mice.

Neuropeptide S Produces Antinociceptive Effects at the Supraspinal Level in Mice

Neuropeptide S Ameliorates Olfactory Spatial Memory Impairment Induced by Scopolamine and MK801 Through Activation of Cognate Receptor-Expressing Neurons in the Subiculum Complex

Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice.

Neuropeptide S Receptor variant (I107N) regulates behavioral characteristics and NPS effect in mice in a sex-dependent manner

Neuropeptide S Counteracts Paradoxical Sleep Deprivation-Induced Anxiety-Like Behavior and Sleep Disturbances

Human-Specific Neuropeptide S Receptor Variants Regulate Fear Extinction in the Basal Amygdala of Male and Female Mice Depending on Threat Salience

Neuropeptide S Enhances Memory and Mitigates Memory Impairment Induced by MK801, Scopolamine or Aβ1–42 in Mice Novel Object and Object Location Recognition Tasks

Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues

Central Neuropeptide S Inhibits Distal Colonic Transit Through Activation of Central Neuropeptide S Receptor in Mice

Neuropeptide S Promotes Wakefulness Through Activation of the Posterior Hypothalamic Histaminergic and Orexinergic Neurons.

Hypothalamic Neuronal Targets Activated by Neuropeptide S

Neuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons

Effect of Intrathecal Injection of Neuropeptide S and Gabapentin on Pain and Anxiety Behavior in Rats with Neuropathic Pain

Antidepressant-like Effects of Neuropeptide SF (NPSF)

Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus